Xueqing Hu

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 5

Top Topics

Drug Administration

Papillary Thyroid

Top Venues

OncoTargets and therapy

NPJ precision oncology

Molecular cancer therapeutics

This page only lists publications with an associated author ORCID identifier.

Publications

Ziwei Wang, Mengyao Li, Ling Bi, Xueqing Hu, Yan Wang
Traditional Chinese Medicine in Regulating Tumor Microenvironment. OncoTargets and therapy 17 (2024)
Ziwei Wang, Mengyao Li, Ling Bi, Xueqing Hu, Yan Wang
Traditional Chinese Medicine in Regulating Tumor Microenvironment. OncoTargets and therapy 17 (2024)
Ziwei Wang, Mengyao Li, Ling Bi, Xueqing Hu, Yan Wang
Traditional Chinese Medicine in Regulating Tumor Microenvironment. OncoTargets and therapy 17 (2024)
Ujjwol Khatri, Neetu Dayal, Xueqing Hu, Elizabeth Larocque, Nimishetti Naganna, Tao Shen, Xuan Liu, Frederick W Holtsberg, M Javad Aman, Herman O Sintim, Jie Wu
Targeting RET Solvent-Front Mutants with Alkynyl Nicotinamide-Based Inhibitors. Molecular cancer therapeutics (2023)
Tao Shen, Xueqing Hu, Xuan Liu, Vivek Subbiah, Blaine H M Mooers, Jie Wu
The L730V/I RET roof mutations display different activities toward pralsetinib and selpercatinib. NPJ precision oncology 5 (1) (2021)